Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sol Efroni

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Cell Transplantation|February 7, 2016
Experimental Support for the Ecoimmunity Theory: Distinct Phenotypes of Nonlymphocytic Cells in SCID and Wild-Type MiceDavid E Ochayon, Boris M Baranovski, Peter Malkin, et al.
Journal of Neurochemistry|June 22, 2019
Astrocyte-specific transcriptome analysis using the ALDH1L1 bacTRAP mouse reveals novel biomarkers of astrogliosis in response to neurotoxicityLindsay T Michalovicz, Kimberly A Kelly, Saurabh Vashishtha, et al.
Nature Communications|July 5, 2020
Predicting and affecting response to cancer therapy based on pathway-level biomarkersRotem Ben-Hamo, Adi Jacob Berger, Nancy Gavert, et al.
Cell Reports|March 15, 2016
System-wide Analysis of the T Cell ResponseRuxandra Covacu, Hagit Philip, Merja Jaronen, et al.
Cell Communication and Signaling : CCS|April 8, 2015
Distinct inhibitory effects on mTOR signaling by ethanol and INK128 in diffuse large B-cell lymphomaKrystyna Mazan-Mamczarz, Raymond J Peroutka, James J Steinhardt, et al.
Nature Immunology|September 3, 2013
IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39Ivan D Mascanfroni, Ada Yeste, Silvio M Vieira, et al.
Cell Stem Cell|May 9, 2008
Global transcription in pluripotent embryonic stem cellsSol Efroni, Radharani Duttagupta, Jill Cheng, et al.
Nature Communications|April 25, 2018
Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1Yinghua Zhu, Yujie Liu, Chao Zhang, et al.
Acta Neuropathologica Communications|December 7, 2018
Immunological analysis of phase II glioblastoma dendritic cell vaccine (Audencel) trial: immune system characteristics influence outcome and Audencel up-regulates Th1-related immunovariablesFriedrich Erhart, Johanna Buchroithner, René Reitermaier, et al.
Science (New York, N.Y.)|October 7, 2016
The linker histone H1.0 generates epigenetic and functional intratumor heterogeneityCristina Morales Torres, Alva Biran, Matthew J Burney, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Cell Transplantation|February 7, 2016
Experimental Support for the Ecoimmunity Theory: Distinct Phenotypes of Nonlymphocytic Cells in SCID and Wild-Type MiceDavid E Ochayon, Boris M Baranovski, Peter Malkin, et al.
Journal of Neurochemistry|June 22, 2019
Astrocyte-specific transcriptome analysis using the ALDH1L1 bacTRAP mouse reveals novel biomarkers of astrogliosis in response to neurotoxicityLindsay T Michalovicz, Kimberly A Kelly, Saurabh Vashishtha, et al.
Nature Communications|July 5, 2020
Predicting and affecting response to cancer therapy based on pathway-level biomarkersRotem Ben-Hamo, Adi Jacob Berger, Nancy Gavert, et al.
Cell Reports|March 15, 2016
System-wide Analysis of the T Cell ResponseRuxandra Covacu, Hagit Philip, Merja Jaronen, et al.
Cell Communication and Signaling : CCS|April 8, 2015
Distinct inhibitory effects on mTOR signaling by ethanol and INK128 in diffuse large B-cell lymphomaKrystyna Mazan-Mamczarz, Raymond J Peroutka, James J Steinhardt, et al.
Nature Immunology|September 3, 2013
IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39Ivan D Mascanfroni, Ada Yeste, Silvio M Vieira, et al.
Cell Stem Cell|May 9, 2008
Global transcription in pluripotent embryonic stem cellsSol Efroni, Radharani Duttagupta, Jill Cheng, et al.
Nature Communications|April 25, 2018
Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1Yinghua Zhu, Yujie Liu, Chao Zhang, et al.
Acta Neuropathologica Communications|December 7, 2018
Immunological analysis of phase II glioblastoma dendritic cell vaccine (Audencel) trial: immune system characteristics influence outcome and Audencel up-regulates Th1-related immunovariablesFriedrich Erhart, Johanna Buchroithner, René Reitermaier, et al.
Science (New York, N.Y.)|October 7, 2016
The linker histone H1.0 generates epigenetic and functional intratumor heterogeneityCristina Morales Torres, Alva Biran, Matthew J Burney, et al.
Pageof 8